Proxima AB has acquired Björkhagen Vårdcentral AB
Proxima AB, a Swedish private equity-owned medical care provider, has acquired Björkhagen Vårdcentral AB from the management team for an undisclosed consideration.
Proxima is a private healthcare group owned by CapMan, a private equity company listed on the Finnish stock exchange. Proxima is active in primary healthcare, diagnostics and specialist healthcare. Specialist healthcare is conducted in Nacka hospital, Motala hospital and the surgical clinic in Östermalm, Stockholm. "The acquisition of Björkhagens Vårdcentral is yet another step in our goal to offer our patients the best and most extensive local hospital care," said Thomas Andersson, CEO of Proxima primary care.
Björkhagen is located in the south of Stockholm, an area with large growth potential. The proximity to Nacka hospital, where Proxima conducts extensive specialist healthcare, will benefit patients. The healthcare center in Björkhagen was founded in 2001, when it was taken over by the county council.
Oaklins' team in Sweden advised the buyer in this transaction. This transaction is the first in a series of acquisitions following an initial strategic analysis resulting in a growth-oriented business plan that includes strategic acquisitions for Proxima AB.
Talk to the deal team
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn more